Who is KESHO?
Kenya Society of Haematology and Oncology (KESHO) was founded in 2002.
Its main objectives at inception were:
- To be a catalyst for research in cancer and blood diseases
- To help improve patient care and stimulate capacity building for cancer care both regionally and nationally.
- To provide physicians involved in diagnosis and treatment of cancer and blood diseases with a forum to discuss ideas for purposes of improving practice and outcomes.
Dr Sitna Mwanzi
Chair, Kenya Society of Haematology and Oncology (KESHO) and Consultant Medical Oncologist at Aga Khan University Hospital, Nairobi
Dr Asim Jamal
Associate Professor and Division Chief of medical oncology at Aga Khan University Hospital, Nairobi
Prof Nicholas Abinya
Section Head, Haematology/Oncology, Department of Clinical Medicine and Therapeutics, University of Nairobi and Kenyatta National Hospital
Dr Andrew Odhiambo
Secretary of KESHO, Lecturer, University of Nairobi and Consultant Medical Oncologist, Nairobi Radiotherapy & Cancer Centre.
Mr David Makumi
Chair, Kenya Network of Cancer Organizations (KENCANCER)
Dr Fredrick Chite
Medical Oncologist and Hematologist, AMPATH Oncology Institute in Eldoret
Clinical Oncologist, Texas Cancer Centre Nairobi and Kenyatta National Hospital
Mr Fred Asige
Radiation Technologist, The Nairobi Hospital
Dr Zipporah Ali
Executive Director of Kenya Hospices and Palliative Care Association (KEHPCA)
Dr Ann Korir
Head, Cancer Registry, KEMRI and Chairperson, Kenya Cancer Association
Dr Anthony Nderitu
Consultant in Clinical Oncology and Radiotherapy, KNH/ Nairobi Hospital
Dr Peter Oyiro
Fellow Haematology-Oncology, University of Nairobi.